Regenic

Regenic is a biotechnology company based in Malaysia that specializes in regenerative medicine and advanced cellular therapies. The company operates a state-of-the-art cGMP-certified laboratory focused on the isolation, expansion, and clinical application of Mesenchymal Stem Cells (MSCs) and Natural Killer (NK) cells. Regenic targets a wide range of conditions, including osteoarthritis, chronic degenerative diseases, and immune system enhancement, while also providing exosome-based treatments for aesthetics and wound healing. By integrating laboratory research with clinical practice, the company aims to provide personalized regenerative solutions to improve patient quality of life. Regenic serves as a key player in the Southeast Asian biotech landscape, collaborating with medical professionals to deliver standardized cell-based interventions.